Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
40.4M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
101
-
Shares change
-
-181K
-
Total reported value, excl. options
-
$2K
-
Value change
-
-$2.38M
-
Number of sells
-
-9
-
Price
-
$19.80
Significant Holders of Pulmonx Corp - COMMON STOCK (LUNG) as of Q3 2023
17 filings reported holding LUNG - Pulmonx Corp - COMMON STOCK as of Q3 2023.
Pulmonx Corp - COMMON STOCK (LUNG) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 101 shares
of 40.4M outstanding shares and own 0% of the company stock.
Largest 10 shareholders include NORGES BANK (377K shares), Voya Investment Management LLC (15.1K shares), NEW YORK STATE COMMON RETIREMENT FUND (13.2K shares), CITADEL ADVISORS LLC (3.55K shares), CWM, LLC (51 shares), BENJAMIN F. EDWARDS & COMPANY, INC. (50 shares), ACADIAN ASSET MANAGEMENT LLC (0 shares), Weiss Multi-Strategy Advisers LLC (0 shares), SG Americas Securities, LLC (0 shares), and Cubist Systematic Strategies, LLC (0 shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.